Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: J Natl Compr Canc Netw. 2019 Jan;17(1):22–28. doi: 10.6004/jnccn.2018.7079

Figure 1.

Figure 1.

Diagram illustrating selection of a cohort of newly diagnosed elderly patients with multiple myeloma who received antineoplastic therapy in SEER-Medicare, 2012–2013. These patients were evaluated for bisphosphonate use.